v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Common Stock
Notes
Common Stock
Convertible debt
Common Stock
Additional Paid-in Capital
Notes
Additional Paid-in Capital
Convertible debt
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Notes
Convertible debt
Total
Balance beginning at Dec. 31, 2024           $ 275,383 $ 329 $ (290,400)     $ (14,688)
Balance beginning, shares at Dec. 31, 2024     913,976                
Stockholders' deficit                      
Stock based compensation           2,828         2,828
Stock based compensation, shares     134                
Issuance of common stock from options exercised           85         85
Issuance of common stock from options exercised, shares     3,391                
Issuance of common stock for debt restructuring and note conversions for convertible debt       $ 1,532         $ 1,532    
Issuance of common stock for debt restructuring and note conversions for convertible debt, shares 11,307                    
Net Income (Loss)               (11,934)     (11,934)
Foreign currency translation adjustments             (131)       (131)
Balance ending at Jun. 30, 2025           279,828 198 (302,334)     (22,308)
Balance ending, shares at Jun. 30, 2025     928,808                
Balance beginning at Mar. 31, 2025           276,356 257 (296,232)     (19,619)
Balance beginning, shares at Mar. 31, 2025     913,976                
Stockholders' deficit                      
Stock based compensation           1,843         1,843
Stock based compensation, shares     134                
Issuance of common stock from options exercised           97         97
Issuance of common stock from options exercised, shares     3,391                
Issuance of common stock for debt restructuring and note conversions for convertible debt       1,532         1,532    
Issuance of common stock for debt restructuring and note conversions for convertible debt, shares 11,307                    
Net Income (Loss)               (6,102)     (6,102)
Foreign currency translation adjustments             (59)       (59)
Balance ending at Jun. 30, 2025           279,828 198 (302,334)     (22,308)
Balance ending, shares at Jun. 30, 2025     928,808                
Balance beginning at Dec. 31, 2025           293,137 143 (315,788)     $ (22,508)
Balance beginning, shares at Dec. 31, 2025     1,294,142               1,294,142
Stockholders' deficit                      
Stock based compensation     $ 1     3,143         $ 3,144
Stock based compensation, shares     10,003                
Issuance of common stock for debt restructuring and note conversions for convertible debt       7,725 $ 3,533       7,725 $ 3,533  
Issuance of common stock for debt restructuring and note conversions for convertible debt, shares 5,516,681 30,195,786                  
Common stock issued in connection with abeyance shares           937         937
Issuance of common stock under equity line of credit, net           147         147
Issuance of common stock under equity line of credit, shares     41,600                
Issuance of Series P Preferred Stock warrants           209         209
Net Income (Loss)               (6,270)     (6,270)
Foreign currency translation adjustments             (102)       (102)
Balance ending at Jun. 30, 2026     $ 1     308,831 41 (322,058)     $ (13,185)
Balance ending, shares at Jun. 30, 2026     37,058,212               37,058,212
Balance beginning at Mar. 31, 2026     $ 1     296,867 100 (322,346)     $ (25,378)
Balance beginning, shares at Mar. 31, 2026     1,619,841                
Stockholders' deficit                      
Stock based compensation           1,592         1,592
Stock based compensation, shares     4,278                
Issuance of common stock for debt restructuring and note conversions for convertible debt       $ 5,902 $ 3,533       $ 5,902 $ 3,533  
Issuance of common stock for debt restructuring and note conversions for convertible debt, shares 5,238,307 30,195,786                  
Common stock issued in connection with abeyance shares           937         937
Net Income (Loss)               288     288
Foreign currency translation adjustments             (59)       (59)
Balance ending at Jun. 30, 2026     $ 1     $ 308,831 $ 41 $ (322,058)     $ (13,185)
Balance ending, shares at Jun. 30, 2026     37,058,212               37,058,212